论文部分内容阅读
目的:探讨格列美脲在糖尿病患者治疗中的应用效果,评价其安全性。方法:选取我院收治的78例糖尿病患者作为研究对象进行分析,随机分成观察组和对照组,观察两组患者治疗的效果。结果:观察组治疗的效果明显优于对照组P<0.05,有统计学意义。另外,观察组患者中没有出现1例严重的不良反应,说明治疗的安全性比较高。结论:采用格列美脲来治疗糖尿病可以降低患者的血糖水平,减少并发症的发生,并且治疗的安全性比较高,值得在临床上推广和应用。
Objective: To investigate the effect of glimepiride in the treatment of diabetic patients and evaluate its safety. Methods: Seventy eight patients with diabetes mellitus admitted to our hospital were selected as study subjects and randomly divided into observation group and control group. The therapeutic effects of two groups were observed. Results: The observation group was significantly better than the control group P <0.05, with statistical significance. In addition, the observation group did not appear in patients with a serious adverse reaction, indicating the safety of treatment is relatively high. Conclusion: The treatment of diabetes with glimepiride can reduce the blood sugar level of patients and reduce the incidence of complications, and the safety of treatment is relatively high, which is worth to be popularized and applied clinically.